Informations générales (source: ClinicalTrials.gov)
Observational Study on the Use of Infant Formulas Based on Rice Protein Hydrolysate in Real Life Conditions
Observational
Mead Johnson Nutrition (Voir sur ClinicalTrials)
mars 2024
décembre 2025
05 avril 2025
The main purpose of this study is to describe the pattern of RIF consumption in real life
conditions, whatever the reasons of initiation and the chosen formula. The main objective
is to study the reasons for prescribing a RIF during the first year of life, as per the
pediatrician. Consumption started before 6 months of age, when milk and infantile
formulas predominates in the baby's feeding, is of particular interest.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL NOVO | ENGLENDER | 14/02/2025 09:03:18 | Contacter | ||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Hospitalier d'Auxerre - Neonatology and pediatric emergency department - 89011 - Auxerre - France | Bertrand Soto, MD | Contact (sur clinicalTrials) | |||
| Centre Hospitalier de Montauban - Pediatric Department - Montauban - France | Pierre Moulin, MD | Contact (sur clinicalTrials) | |||
| Centre Hospitalier Universitaire de Nantes - Pediatric emergency department - 44093 - Nantes - France | Hugues Piloquet, MD | Contact (sur clinicalTrials) | |||
| Dr Christine REGIMBART - Private Practice - 49026 - Bécon-les-Granits - Becon-les-Granits - France | Christine Regimbart, MD | Contact (sur clinicalTrials) | |||
| Dr Frederic Couttenier Private Practice - 59551 - Attiches - France | Frederic Couttenier, MD | Contact (sur clinicalTrials) | |||
| Dr Marta Nowak-Mohamed - Private Practice - 03200 - Vichy - France | Contact (sur clinicalTrials) | ||||
| Dr. Amandine Blasquez Private Practice - 33500 - Libourne - France | Amandine Blasquez, MD | Contact (sur clinicalTrials) | |||
| Dr. Anne Cheve Private Practice - 29200 - Brest - France | Anne Cheve, MD | Contact (sur clinicalTrials) | |||
| Dr. Anne Sengier - Private Practice - 76600 - Le Havre - France | Anne Sengier, MD | Contact (sur clinicalTrials) | |||
| Dr. Karim Abada Private Practice - 09017 - Foix - France | Karim Abada, MD | Contact (sur clinicalTrials) | |||
| Dr. Marc Sznajder Private Practice - 75011 - Paris - France | Marc Sznajder, MD | Contact (sur clinicalTrials) | |||
| Dr. Nellie Houeto Private Practice - 83400 - Hyères - France | Nellie Houeto | Contact (sur clinicalTrials) | |||
| Dr. Piotr Gembara Private Practice - 03200 - Vichy - France | Piotr Gembara, MD | Contact (sur clinicalTrials) | |||
| Dr. Sandra Brancato Private Practice - 30190 - Brignon - France | Contact (sur clinicalTrials) | ||||
| Elise Foy-Foulkes Private Practice - 92100 - Boulogne-Billancourt - France | Elise Foy-Foulkes, MD | Contact (sur clinicalTrials) | |||
| Scm Les Pediatrices Du Pic St Loup - 34980 - St Clement - DE Riviere - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
- Child aged between 6 and 36 months,
- Child who has already consumed a RIF for at least one month, or still consuming a
RIF, or who will benefit from taking a RIF, according to the pediatrician,
- Legal representatives (parents/guardians) deemed capable of following the
requirements of the protocol and have given their consent orally.
- Child aged between 6 and 36 months,
- Child who has already consumed a RIF for at least one month, or still consuming a
RIF, or who will benefit from taking a RIF, according to the pediatrician,
- Legal representatives (parents/guardians) deemed capable of following the
requirements of the protocol and have given their consent orally.
- Child with a clinically relevant and significant abnormality in the medical history
or on physical examination;
- Child who has been hospitalized in a neonatology unit (due to prematurity,
malformation or neonatal pathology), or born with a low birth weight (≤ 2,500 g);
- For children not diversified at the time of starting RIF: mixed feeding with RIF and
breast milk and/or infant formula based on cow's milk;
- Child born to minor parent(s);
- Infant or infant's family unable to comply with study protocol or procedures, in the
judgment of the investigator;
- Participation in any other clinical trial prior to inclusion;
- Refusal of the Parents / legal representatives of the child, or who do not master
the French language well enough to understand the information letter.